Epidemiological characteristics of human prion diseases

Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per milli...

Full description

Saved in:
Bibliographic Details
Published in:Infectious diseases of poverty 2016-06, Vol.5 (1), p.47-47, Article 47
Main Authors: Chen, Cao, Dong, Xiao-Ping
Format: Article
Language:English
Subjects:
Epidemiological Monitoring
Epidemiology
Humans
Infectious diseases
Prion Diseases - epidemiology
Prion Diseases - etiology
Public Health
Scoping Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83
cites cdi_FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83
container_end_page 47
container_issue 1
container_start_page 47
container_title Infectious diseases of poverty
container_volume 5
creator Chen, Cao
Dong, Xiao-Ping
description Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per million worldwide annually, occurring in sporadic, inherited, and acquired forms. These diseases have attracted both scientific and public attention not only because of their mysterious pathogen, but also due to their considerable threat to public health since the emergence of the variant CJD.There are still no specific therapeutic and prophylactic interventions available for prion diseases, thus active surveillance of human prion diseases is critical for disease control and prevention. Since 1993, CJD surveillance systems have been established in many countries and regions, and several long-term multinational cooperative projects have been conducted.In this paper, the epidemiological characteristics of various human prion diseases and the active surveillance systems pertaining to them in different countries and regions are summarized and reviewed.
doi_str_mv 10.1186/s40249-016-0143-8
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4105853211</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83</originalsourceid><addsrcrecordid>eNpdkUtLAzEUhYMottT-ADcy4MbNaF6Tx0aQUh9QcKPrkMlk2pSZSU1mBP-9GaqlGggJN-ce7skHwCWCtwgJdhcpxFTmELG0KcnFCZhimCpSFvz06D4B8xi3MC0hKKLoHEwwxwUisJgCvty5yrbON37tjG4ys9FBm94GF3tnYubrbDO0ust2wfkuq1y0Otp4Ac5q3UQ7_zln4P1x-bZ4zlevTy-Lh1VuKOZ9jmnBS80oFjUsZckgxiWjtDacCFKVhJcWywpWRQ2ZNhRxQhhh1haVsbqqBJmB-73vbihbm6pdH3Sj0jCtDl_Ka6f-vnRuo9b-U1EhIRU0Gdz8GAT_MdjYq9ZFY5tGd9YPUSEuiUSQMpak1_-kWz-ELsVTSKTfw4UkoyHaq0zwMQZbH4ZBUI1k1J6MSmTUSEaNKa6OUxw6fjmQb_aSiU0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1800825934</pqid></control><display><type>article</type><title>Epidemiological characteristics of human prion diseases</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>NCBI_PubMed Central（免费）</source><creator>Chen, Cao ; Dong, Xiao-Ping</creator><creatorcontrib>Chen, Cao ; Dong, Xiao-Ping</creatorcontrib><description>Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per million worldwide annually, occurring in sporadic, inherited, and acquired forms. These diseases have attracted both scientific and public attention not only because of their mysterious pathogen, but also due to their considerable threat to public health since the emergence of the variant CJD.There are still no specific therapeutic and prophylactic interventions available for prion diseases, thus active surveillance of human prion diseases is critical for disease control and prevention. Since 1993, CJD surveillance systems have been established in many countries and regions, and several long-term multinational cooperative projects have been conducted.In this paper, the epidemiological characteristics of various human prion diseases and the active surveillance systems pertaining to them in different countries and regions are summarized and reviewed.</description><identifier>ISSN: 2049-9957</identifier><identifier>ISSN: 2095-5162</identifier><identifier>EISSN: 2049-9957</identifier><identifier>DOI: 10.1186/s40249-016-0143-8</identifier><identifier>PMID: 27251305</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Epidemiological Monitoring ; Epidemiology ; Humans ; Infectious diseases ; Prion Diseases - epidemiology ; Prion Diseases - etiology ; Public Health ; Scoping Review</subject><ispartof>Infectious diseases of poverty, 2016-06, Vol.5 (1), p.47-47, Article 47</ispartof><rights>Copyright BioMed Central 2016</rights><rights>Chen and Dong. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83</citedby><cites>FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890484/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1800825934?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27251305$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Cao</creatorcontrib><creatorcontrib>Dong, Xiao-Ping</creatorcontrib><title>Epidemiological characteristics of human prion diseases</title><title>Infectious diseases of poverty</title><addtitle>Infect Dis Poverty</addtitle><description>Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per million worldwide annually, occurring in sporadic, inherited, and acquired forms. These diseases have attracted both scientific and public attention not only because of their mysterious pathogen, but also due to their considerable threat to public health since the emergence of the variant CJD.There are still no specific therapeutic and prophylactic interventions available for prion diseases, thus active surveillance of human prion diseases is critical for disease control and prevention. Since 1993, CJD surveillance systems have been established in many countries and regions, and several long-term multinational cooperative projects have been conducted.In this paper, the epidemiological characteristics of various human prion diseases and the active surveillance systems pertaining to them in different countries and regions are summarized and reviewed.</description><subject>Epidemiological Monitoring</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Prion Diseases - epidemiology</subject><subject>Prion Diseases - etiology</subject><subject>Public Health</subject><subject>Scoping Review</subject><issn>2049-9957</issn><issn>2095-5162</issn><issn>2049-9957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkUtLAzEUhYMottT-ADcy4MbNaF6Tx0aQUh9QcKPrkMlk2pSZSU1mBP-9GaqlGggJN-ce7skHwCWCtwgJdhcpxFTmELG0KcnFCZhimCpSFvz06D4B8xi3MC0hKKLoHEwwxwUisJgCvty5yrbON37tjG4ys9FBm94GF3tnYubrbDO0ust2wfkuq1y0Otp4Ac5q3UQ7_zln4P1x-bZ4zlevTy-Lh1VuKOZ9jmnBS80oFjUsZckgxiWjtDacCFKVhJcWywpWRQ2ZNhRxQhhh1haVsbqqBJmB-73vbihbm6pdH3Sj0jCtDl_Ka6f-vnRuo9b-U1EhIRU0Gdz8GAT_MdjYq9ZFY5tGd9YPUSEuiUSQMpak1_-kWz-ELsVTSKTfw4UkoyHaq0zwMQZbH4ZBUI1k1J6MSmTUSEaNKa6OUxw6fjmQb_aSiU0</recordid><startdate>20160602</startdate><enddate>20160602</enddate><creator>Chen, Cao</creator><creator>Dong, Xiao-Ping</creator><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160602</creationdate><title>Epidemiological characteristics of human prion diseases</title><author>Chen, Cao ; Dong, Xiao-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Epidemiological Monitoring</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Prion Diseases - epidemiology</topic><topic>Prion Diseases - etiology</topic><topic>Public Health</topic><topic>Scoping Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Cao</creatorcontrib><creatorcontrib>Dong, Xiao-Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database (Proquest)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infectious diseases of poverty</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Cao</au><au>Dong, Xiao-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiological characteristics of human prion diseases</atitle><jtitle>Infectious diseases of poverty</jtitle><addtitle>Infect Dis Poverty</addtitle><date>2016-06-02</date><risdate>2016</risdate><volume>5</volume><issue>1</issue><spage>47</spage><epage>47</epage><pages>47-47</pages><artnum>47</artnum><issn>2049-9957</issn><issn>2095-5162</issn><eissn>2049-9957</eissn><abstract>Human prion diseases are a group of transmissible, progressive, and invariably fatal neurodegenerative disorders, which include Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome, and fatal familial insomnia. Human prion diseases affect approximately 1-2 persons per million worldwide annually, occurring in sporadic, inherited, and acquired forms. These diseases have attracted both scientific and public attention not only because of their mysterious pathogen, but also due to their considerable threat to public health since the emergence of the variant CJD.There are still no specific therapeutic and prophylactic interventions available for prion diseases, thus active surveillance of human prion diseases is critical for disease control and prevention. Since 1993, CJD surveillance systems have been established in many countries and regions, and several long-term multinational cooperative projects have been conducted.In this paper, the epidemiological characteristics of various human prion diseases and the active surveillance systems pertaining to them in different countries and regions are summarized and reviewed.</abstract><cop>England</cop><pub>BioMed Central</pub><pmid>27251305</pmid><doi>10.1186/s40249-016-0143-8</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2049-9957
ispartof Infectious diseases of poverty, 2016-06, Vol.5 (1), p.47-47, Article 47
issn 2049-9957
2095-5162
2049-9957
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890484
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); NCBI_PubMed Central（免费）
subjects Epidemiological Monitoring
Epidemiology
Humans
Infectious diseases
Prion Diseases - epidemiology
Prion Diseases - etiology
Public Health
Scoping Review
title Epidemiological characteristics of human prion diseases
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T01%3A11%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiological%20characteristics%20of%20human%20prion%20diseases&rft.jtitle=Infectious%20diseases%20of%20poverty&rft.au=Chen,%20Cao&rft.date=2016-06-02&rft.volume=5&rft.issue=1&rft.spage=47&rft.epage=47&rft.pages=47-47&rft.artnum=47&rft.issn=2049-9957&rft.eissn=2049-9957&rft_id=info:doi/10.1186/s40249-016-0143-8&rft_dat=%3Cproquest_pubme%3E4105853211%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-2457ba6428f0b9b6022b644fc7383db37be29d0d5f06ac41733636ee5dceadd83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1800825934&rft_id=info:pmid/27251305&rfr_iscdi=true